New therapies in pulmonary arterial hypertension: Recent insights
Pulmonary Arterial Hypertension (PAH) is a complex and progressive disease characterized by elevated pulmonary vascular resistance and right heart failure. Current therapies primarily focus on pulmonary vasodilation; however, novel approaches that target the underlying pathophysiological mechanisms—...
Saved in:
Main Authors: | Giulia Guglielmi, Konstantinos Dimopoulos, S. John Wort |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | International Journal of Cardiology Congenital Heart Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666668525000072 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The contemporary echocardiography approach to diagnosis of pulmonary hypertension and non-invasive estimation of pulmonary artery pressure
by: M.Yu. Kolesnyk
Published: (2018-06-01) -
Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01) -
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
by: Richard Channick, MD, et al.
Published: (2025-02-01) -
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities
by: Yu Enomoto, et al.
Published: (2025-01-01) -
The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
by: Piotr Kędzierski, et al.
Published: (2025-01-01)